Alisquireno: uma nova opção terapêutica na Cardiomiopatia Hipertrófica / Aliskiren: a new therapeutic option in Hypertrophic Cardiomyopathy
Rev. bras. hipertens
; 20(4): 196-199, out.-dez.2013.
Article
in Pt
| LILACS
| ID: biblio-881623
Responsible library:
BR26.1
RESUMO
Caso clínico de Cardiomiopatia Hipertrófica (CMH), que após a introdução do alisquireno, houve regressão da massa do Ventrículo Esquerdo (VE) com remodelamento do VE à custa do aumento da cavidade do VE, associado à diminuição da espessura de suas paredes, com manutenção da função do VE. Também ocorreu desaparecimento do gradiente intraventricular de repouso, e durante o estresse esse gradiente deixou de ser significativo. A análise do Eletrocardiograma (ECG) evidenciou melhora do padrão de repolarização ventricular. De sorte que o paciente foi liberado para realizar atividade física não competitiva e gradual.
ABSTRACT
Clinical case of Hypertrophic Cardiomyopathy (HCM) that after the introduction of aliskiren, there was regression of the Left Ventricle (LV) mass with LV remodeling at the expense of increased LV cavity, associated with decreased thickness of its walls, with maintenance of LV function. There was also disappearance of the intraventricular gradient at rest and during stress, this gradient was no longer significant. The Eletrocardiogram (EKG) analysis showed improvement in ventricular repolarization pattern. So that the patient was released for non-competitive and gradual physical activity.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Cardiomyopathy, Hypertrophic
/
Hypertrophy, Right Ventricular
Limits:
Adult
/
Humans
/
Male
Language:
Pt
Journal:
Rev. bras. hipertens
Journal subject:
CARDIOLOGIA
Year:
2013
Document type:
Article
Affiliation country:
Brazil